J Dig Cancer Res.  2019 Jun;7(1):5-7. 10.0000/jdcr.2019.7.1.5.

Adjuvant Therapy of Pancreatic Cancer

• Paik WH

• KMID: 2455387
• DOI: http://doi.org/10.0000/jdcr.2019.7.1.5

Abstract

Pancreatic cancer is a lethal disease since curative resection is available in only 20% of patients at the initial diagnosis. Even after radical resection of the cancer, most patients experience recurrence. Therefore, many clinical trials have been attempted to prevent recurrence of pancreatic cancer. The key clinical studies about adjuvant therapy of pancreatic cancer and currently available regimens in Korea will be reviewed concisely according to the chemotherapy, radiation therapy, or both.

Keyword

Pancreatic cancer; Adjuvant therapy; FOLFIRINOX; Recurrence

MeSH Terms

Diagnosis
Drug Therapy
Humans
Korea
Pancreatic Neoplasms*
Recurrence